Zien Medical Technologies

Zien Medical Technologies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Zien Medical Technologies, founded in 2018 and headquartered in San Francisco, operates as a full-service partner for medical device development and manufacturing. The company's core value proposition is providing an integrated, capital-efficient path to market for startups and entrepreneurs, leveraging its ISO 13485-certified infrastructure and regulatory expertise to reduce typical development timelines by 12-24 months and costs by up to 70%. By managing design control, manufacturing, packaging, sterilization, and global regulatory compliance, Zien enables its clients to focus on commercialization while it handles the complexities of bringing a physical device to market. It serves a broad range of surgical and interventional specialties, positioning itself as a critical enabler in the digital health and medical device ecosystem.

Interventional RadiologyCardiac SurgeryNeuro-surgeryGynecologicalGastrointestinalAcute CareGeneral Surgery

Technology Platform

Integrated service platform for medical device development and manufacturing, centered on an ISO 13485-certified Quality Management System. Includes capabilities in design control, regulatory strategy, laser cutting, Nitinol processing, process validation, contract packaging, sterilization, and provision of digital Instructions for Use (EIFUs).

Opportunities

The growing number of capital-efficient medtech startups seeking to outsource development creates a large and expanding addressable market.
Increasing regulatory complexity for global market access favors integrated partners who can navigate multiple jurisdictions.
Trends towards minimally invasive surgery and digital health integration drive demand for sophisticated manufacturing and software-enabled device support.

Risk Factors

Revenue is dependent on the success and regulatory approval of client products, creating high client concentration risk.
The business is exposed to significant regulatory and quality system risk, where any major compliance failure could be catastrophic.
Competition from larger CMOs and niche specialists could pressure margins and client acquisition.

Competitive Landscape

Zien competes in the medical device contract development and manufacturing organization (CDMO) space. Competitors range from large, global public CDMOs (e.g., Integer, Flex, Jabil) to smaller, specialized engineering and manufacturing shops. Zien's differentiation is its integrated, full-service model targeted specifically at startups, offering both strategic regulatory guidance as Manufacturer of Record and hands-on manufacturing execution.